12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga·09/04/2025 12:08:12
Listen to the news
Gainers
- Bone Biologics (NASDAQ:BBLG) shares increased by 30.4% to $2.7 during Thursday's pre-market session. The company's market cap stands at $3.3 million.
- NanoVibronix (NASDAQ:NAOV) stock increased by 27.91% to $7.01. The company's market cap stands at $4.3 million.
- Biodesix (NASDAQ:BDSX) shares increased by 23.74% to $0.52. The market value of their outstanding shares is at $61.8 million.
- Aquestive Therapeutics (NASDAQ:AQST) shares increased by 17.65% to $4.65. The company's market cap stands at $477.8 million.
- 4D Molecular Therapeutics (NASDAQ:FDMT) stock moved upwards by 15.91% to $7.5. The market value of their outstanding shares is at $302.1 million.
- EUDA Health Holdings (NASDAQ:EUDA) shares increased by 12.12% to $1.85. The market value of their outstanding shares is at $61.3 million.
Losers
- Agios Pharmaceuticals (NASDAQ:AGIO) stock fell 17.7% to $33.42 during Thursday's pre-market session. The company's market cap stands at $2.3 billion.
- ALT5 Sigma (NASDAQ:ALTS) stock fell 15.93% to $3.77. The market value of their outstanding shares is at $546.0 million.
- Artelo Biosciences (NASDAQ:ARTL) shares declined by 15.07% to $7.44. The company's market cap stands at $11.5 million.
- Aethlon Medical (NASDAQ:AEMD) shares fell 12.6% to $1.18. The market value of their outstanding shares is at $3.5 million.
- Kalaris Therapeutics (NASDAQ:KLRS) shares decreased by 9.63% to $4.13. The company's market cap stands at $85.4 million.
- Sanofi (NASDAQ:SNY) shares decreased by 8.28% to $45.76. The market value of their outstanding shares is at $121.6 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.